ÃÛÌÒ´«Ã½Æƽâ°æÏÂÔØ

Below is a summary assembled by the Research & Innovation Office (RIO). Please see the full solicitation for complete information about the funding opportunity.

Program Summary

The Pathway Accelerator award is intended to provide flexible, long-term salary and research support to early career researchers who are proposing innovative and ambitious diabetes-related research programs, and who have distinguished themselves as exceptionally talented and promising research investigators.

These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes with an emphasis on the investigator’s potential to significantly transform diabetes through research (‘moving the needle’) to improve the lives of people with diabetes.

For this award, demonstration of independent productivity should include that the candidate is currently in an independent faculty position, has demonstrated the ability to perform a particular set of experiments at a high-quality level, including senior author publications (independent of training mentors) and/or has demonstrated the ability to obtain independent funding/support for their work.

Deadlines

CU Internal Deadline: 11:59pm MST May 28, 2025

Sponsor Application Deadline: 3:00pm MST July 23, 2025

Internal Application Requirements (all in PDF format)

• Project Summary (3 pages maximum): Please describe the investigator’s potential to significantly transform diabetes through translationalÌýresearch (‘moving the needle’) to improve the lives of people with diabetes. Also describe the investigator’s proven creativity, collaboration and innovation, and ability to establish an independent research program.
• PI CV / Biosketch
• Budget Overview (up to 1 page): A basic budget outlining project costs is sufficient; detailed OCG budgets are not required.

To access the online application, visit:

Eligibility

Candidate’s must hold a full-time appointment at their sponsoring institution. Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.

Applicants must hold independent faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial NIH R01) but must not have applied for, or received, an NIH R01 renewal or a second R01 award.

Accelerator applicants must agree to devote at least 75% of total time and effort towards research during the period of Association funding with a commitment of 25-50% effort towards the Accelerator Award if funded.

Co-PIs are not permitted.

Limited Submission Guidelines

Each institution is allowed one Accelerator Award nomination.

Award Information

Accelerator Award: $325,000/year over 5 years

Review Criteria

Principal Investigator:

• Proven ability to establish independent research program.
• Proven ability for creativity, collaboration, and innovation
• Institutional commitment

Research Strategy:

• Innovation and creativity
• Potential impact for understanding/treatment of diabetes
• Clarity of thought and approach